GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (NAS:MNOV) » Definitions » Shiller PE Ratio

MediciNova (MediciNova) Shiller PE Ratio : (As of May. 23, 2024)


View and export this data going back to 2006. Start your Free Trial

What is MediciNova Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MediciNova Shiller PE Ratio Historical Data

The historical data trend for MediciNova's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediciNova Shiller PE Ratio Chart

MediciNova Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MediciNova Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MediciNova's Shiller PE Ratio

For the Biotechnology subindustry, MediciNova's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediciNova's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MediciNova's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MediciNova's Shiller PE Ratio falls into.



MediciNova Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MediciNova's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, MediciNova's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.06/131.7762*131.7762
=-0.060

Current CPI (Mar. 2024) = 131.7762.

MediciNova Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.090 100.560 -0.118
201409 -0.100 100.428 -0.131
201412 -0.100 99.070 -0.133
201503 -0.090 99.621 -0.119
201506 -0.092 100.684 -0.120
201509 -0.060 100.392 -0.079
201512 -0.090 99.792 -0.119
201603 -0.110 100.470 -0.144
201606 -0.100 101.688 -0.130
201609 -0.080 101.861 -0.103
201612 -0.040 101.863 -0.052
201703 -0.090 102.862 -0.115
201706 -0.080 103.349 -0.102
201709 -0.110 104.136 -0.139
201712 -0.050 104.011 -0.063
201803 -0.120 105.290 -0.150
201806 -0.080 106.317 -0.099
201809 -0.160 106.507 -0.198
201812 -0.010 105.998 -0.012
201903 -0.110 107.251 -0.135
201906 -0.090 108.070 -0.110
201909 -0.050 108.329 -0.061
201912 -0.040 108.420 -0.049
202003 -0.060 108.902 -0.073
202006 -0.100 108.767 -0.121
202009 -0.080 109.815 -0.096
202012 -0.060 109.897 -0.072
202103 -0.004 111.754 -0.005
202106 -0.090 114.631 -0.103
202109 -0.070 115.734 -0.080
202112 -0.040 117.630 -0.045
202203 -0.070 121.301 -0.076
202206 -0.080 125.017 -0.084
202209 -0.070 125.227 -0.074
202212 -0.060 125.222 -0.063
202303 -0.060 127.348 -0.062
202306 -0.060 128.729 -0.061
202309 -0.010 129.860 -0.010
202312 -0.040 129.419 -0.041
202403 -0.060 131.776 -0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MediciNova  (NAS:MNOV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


MediciNova Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of MediciNova's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MediciNova (MediciNova) Business Description

Traded in Other Exchanges
Address
4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Executives
Nicole Lemerond director 3 MURRAY HILL ROAD, SCARSDALE NY 10583
Hideki Nagao director 4350 LA JOLLA VILLAGE DRIVE, SUITE 950, SAN DIEGO CA 92122
Jason J Kruger officer: Chief Financial Officer 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA CA 92037
Douglas Paulin officer: Chief Financial Officer 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA CA 92037
Gaeta Federico C.a. officer: Chief Scientific Officer 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA CA 92037
3d Investment Partners Pte. Ltd. 10 percent owner 250 NORTH BRIDGE ROAD, #13-01 RAFFLES CITY TOWER, SINGAPORE U0 179101
3d Opportunity Master Fund 10 percent owner C/O MAPLES CORPORATE SERVICES LIMITED, PO BOX 309, UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Carolyn Beaver director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
Stepanow Edward C Jr. officer: Chief Financial Officer 4275 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA 92037
Kazuko Matsuda officer: Chief Medical Officer C/O MEDICINOVA, INC., 4275 EXECUTIVE SQUARE, SUITE 650, LA JOLLA CA 92037
Yuichi Iwaki director C/O MEDICINOVA, INC., 4275 EXECUTIVE SQUARE, SUITE 650, LA JOLLA CA 92037
Carla Reyes officer: Chief Financial Officer 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA CA 92037
Yoshio Ishizaka director 4275 EXECUTIVE SQUARE, SUITE 650, LA JOLLA CA 92037
Yutaka Kobayashi director 4275 EXECUTIVE SQUARE, SUITE 650, LA JOLLA CA 92037
Geoffrey Obrien officer: Vice President 4275 EXECUTIVE SQUARE, SUITE 650, LA JOLLA CA 92037

MediciNova (MediciNova) Headlines

From GuruFocus